FBTCX vs. SWHFX
Compare and contrast key facts about Fidelity Advisor Biotechnology Fund Class C (FBTCX) and Schwab Health Care Fund™ (SWHFX).
FBTCX is managed by Fidelity. It was launched on Dec 27, 2000. SWHFX is managed by Charles Schwab. It was launched on Jul 2, 2000.
Performance
FBTCX vs. SWHFX - Performance Comparison
Loading graphics...
FBTCX vs. SWHFX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FBTCX Fidelity Advisor Biotechnology Fund Class C | 2.09% | 38.48% | -2.00% | 9.86% | -8.64% | -3.72% | 31.17% | 24.82% | -4.55% | 24.81% |
SWHFX Schwab Health Care Fund™ | -2.94% | 9.81% | 0.10% | 0.73% | -4.66% | 23.36% | 12.83% | 17.64% | 3.68% | 20.31% |
Returns By Period
In the year-to-date period, FBTCX achieves a 2.09% return, which is significantly higher than SWHFX's -2.94% return. Over the past 10 years, FBTCX has outperformed SWHFX with an annualized return of 10.32%, while SWHFX has yielded a comparatively lower 7.78% annualized return.
FBTCX
- 1D
- 5.09%
- 1M
- -0.81%
- YTD
- 2.09%
- 6M
- 15.10%
- 1Y
- 54.26%
- 3Y*
- 17.00%
- 5Y*
- 6.73%
- 10Y*
- 10.32%
SWHFX
- 1D
- 2.06%
- 1M
- -6.53%
- YTD
- -2.94%
- 6M
- -1.82%
- 1Y
- 1.02%
- 3Y*
- 3.81%
- 5Y*
- 4.40%
- 10Y*
- 7.78%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FBTCX vs. SWHFX - Expense Ratio Comparison
FBTCX has a 1.75% expense ratio, which is higher than SWHFX's 0.80% expense ratio.
Return for Risk
FBTCX vs. SWHFX — Risk / Return Rank
FBTCX
SWHFX
FBTCX vs. SWHFX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Biotechnology Fund Class C (FBTCX) and Schwab Health Care Fund™ (SWHFX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FBTCX | SWHFX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.90 | -0.02 | +1.91 |
Sortino ratioReturn per unit of downside risk | 2.49 | 0.10 | +2.39 |
Omega ratioGain probability vs. loss probability | 1.32 | 1.01 | +0.31 |
Calmar ratioReturn relative to maximum drawdown | 3.08 | 0.00 | +3.08 |
Martin ratioReturn relative to average drawdown | 12.19 | 0.01 | +12.19 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FBTCX | SWHFX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.90 | -0.02 | +1.91 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.29 | 0.31 | -0.02 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.42 | 0.49 | -0.07 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.27 | 0.50 | -0.23 |
Correlation
The correlation between FBTCX and SWHFX is 0.73, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
FBTCX vs. SWHFX - Dividend Comparison
FBTCX's dividend yield for the trailing twelve months is around 1.65%, while SWHFX has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBTCX Fidelity Advisor Biotechnology Fund Class C | 1.65% | 1.68% | 0.00% | 0.00% | 0.00% | 24.50% | 9.78% | 7.92% | 2.92% | 0.00% | 0.00% | 5.73% |
SWHFX Schwab Health Care Fund™ | 0.00% | 0.00% | 9.49% | 3.60% | 4.18% | 12.52% | 11.47% | 4.56% | 10.02% | 7.32% | 2.63% | 16.31% |
Drawdowns
FBTCX vs. SWHFX - Drawdown Comparison
The maximum FBTCX drawdown since its inception was -64.04%, which is greater than SWHFX's maximum drawdown of -43.10%. Use the drawdown chart below to compare losses from any high point for FBTCX and SWHFX.
Loading graphics...
Drawdown Indicators
| FBTCX | SWHFX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -64.04% | -43.10% | -20.94% |
Max Drawdown (1Y)Largest decline over 1 year | -13.63% | -12.25% | -1.38% |
Max Drawdown (5Y)Largest decline over 5 years | -37.26% | -19.35% | -17.91% |
Max Drawdown (10Y)Largest decline over 10 years | -39.37% | -27.28% | -12.09% |
Current DrawdownCurrent decline from peak | -2.75% | -10.00% | +7.25% |
Average DrawdownAverage peak-to-trough decline | -23.21% | -8.15% | -15.06% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.75% | 5.66% | -1.91% |
Volatility
FBTCX vs. SWHFX - Volatility Comparison
Fidelity Advisor Biotechnology Fund Class C (FBTCX) has a higher volatility of 9.37% compared to Schwab Health Care Fund™ (SWHFX) at 5.00%. This indicates that FBTCX's price experiences larger fluctuations and is considered to be riskier than SWHFX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FBTCX | SWHFX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.37% | 5.00% | +4.37% |
Volatility (6M)Calculated over the trailing 6-month period | 17.02% | 12.23% | +4.79% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.99% | 18.26% | +7.73% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.48% | 14.49% | +8.99% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.66% | 15.93% | +8.73% |